The abstract is read at the publisher; the summary is JClub's.
Rationally modifying lipid nanoparticle composition restores robust CRISPR-SpCas9 genome editing in human umbilical vein endothelial cells (HUVECs), enabling efficient VEGFA and HIF1A edits in 2D and 3D microfluidic flow models.
- Why it matters: Efficient, cell-type-specific CRISPR delivery is a major barrier in vascular endothelial cells, where conventional LNPs support mRNA delivery but fail to produce editing.
- What they did: The study tested LNP-mediated mRNA and CRISPR delivery in HUVECs versus HEK293T cells, identifying reduced SpCas9 mRNA translation as a key endothelial bottleneck and optimizing lipid composition to boost SpCas9 protein expression.
- The result: With the optimized LNP, genome editing is achieved in HUVECs in both 2D culture and physiologically relevant 3D microfluidic endothelial systems that mimic flow conditions in vivo.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.